U.S. Markets open in 7 hrs 8 mins

Free Pre-Market Technical Recap on Genesis Healthcare and Three Additional Healthcare Stocks

Stock Research Monitor: BKD, EVHC, and XLRN

LONDON, UK / ACCESSWIRE / July 18, 2018 / If you want a free Stock Review on GEN sign up now at www.wallstequities.com/registration. On Tuesday, July 17, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged higher at the closing bell. Six out of nine sectors ended Tuesday's trading session in bullish territories. Taking into consideration yesterday's market sentiment, WallStEquities.com assessed the following Healthcare equities this morning: Brookdale Senior Living Inc. (NYSE: BKD), Envision Healthcare Corp. (NYSE: EVHC), Genesis Healthcare Inc. (NYSE: GEN), and Acceleron Pharma Inc. (NASDAQ: XLRN). All you have to do is sign up today for this free limited time offer by clicking the link below: www.wallstequities.com/registration.

Brookdale Senior Living

On Tuesday, shares in Brentwood, Tennessee headquartered Brookdale Senior Living Inc. recorded a trading volume of 2.62 million shares. The stock ended at $9.36, rising 0.65% from the last trading session. The Company's shares have gained 38.87% over the previous three months. The stock is trading above its 50-day and 200-day moving averages by 8.57% and 5.61%, respectively. Furthermore, shares of the Company, which owns and operates senior living communities in the US, have a Relative Strength Index (RSI) of 52.50. Get the full research report on BKD for free by clicking below at: www.wallstequities.com/registration/?symbol=BKD.

Envision Healthcare

Nashville, Tennessee-based Envision Healthcare Corp.'s stock finished yesterday's session 0.36% higher at $44.85. A total volume of 1.42 million shares was traded. The Company's shares have gained 17.65% over the previous three months. The stock is trading above its 50-day and 200-day moving averages by 3.45% and 17.33%, respectively. Furthermore, shares of Envision Healthcare, which through its subsidiaries, provides various healthcare services in the US, have an RSI of 61.95. To experience our free membership services anytime/ anywhere and access the free report on EVHC, click to register at: www.wallstequities.com/registration/?symbol=EVHC.

Genesis Healthcare

At the close of trading on Tuesday, shares in Kennett Square, Pennsylvania headquartered Genesis Healthcare Inc. saw a decline of 5.84%, ending the day at $1.45. The stock recorded a trading volume of 1.08 million shares, which was higher than its three months average volume of 897.19 thousand shares. The stock is trading above its 200-day moving average by 6.05%. Moreover, shares of Genesis Healthcare, which together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the US, have an RSI of 29.38. Join our big investor community at Wall St. Equities today and get your free report on GEN at: www.wallstequities.com/registration/?symbol=GEN.

Acceleron Pharma

Cambridge, Massachusetts headquartered Acceleron Pharma Inc.'s shares ended the day 0.72% higher at $46.29 with a total trading volume of 282,635 shares. The stock has gained 28.51% in the last month, 21.94% in the previous three months, and 46.95% over the last twelve months. The Company's shares are trading above their 50-day and 200-day moving averages by 20.70% and 18.22%, respectively. Additionally, shares of Acceleron Pharma, which focuses on the discovery, development, and commercialization of therapeutics to treat serious and rare diseases, have an RSI of 64.23.

On July 13th, 2018, research firm Morgan Stanley downgraded the Company's stock rating from 'Overweight' to 'Equal-Weight'. Know more about XLRN in our free research coverage at: www.wallstequities.com/registration/?symbol=XLRN.

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.


WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit



For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com
Phone number: 21 32 044 483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities